OPERA - Incorporating Robotic Surgery in Both Mastectomy and DIEP Flap Reconstruction - Trial NCT06415526
Access comprehensive clinical trial information for NCT06415526 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Completed. The study focuses on Breast Cancer,Mastectomy; Lymphedema. Target enrollment is 14 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung Memorial Hospital
Timeline & Enrollment
N/A
May 03, 2024
May 10, 2024
Primary Outcome
ARS incision,Robotic time,Flap size
Summary
Current breast cancer surgery is achieving minimally invasive approach to reduce incision
 while providing better surgical vision and freedom in mastectomy. Breast reconstruction with
 free deep inferior epigastric artery perforator (DIEP) flap was considered the gold standard,
 however, the donor site morbidity remains an endless concern. Here we applied
 robotic-assisted surgery in both mastectomy and free DIEP flap harvest, so-called Oncoplastic
 Entirely Robot-Assisted Approach (OPERA).
 
 A retrospective chart review identified 14 patients with unilateral breast cancer received
 robotic-assisted mastectomy and robotic assisted free DIEP flap harvest for breast
 reconstruction. The patient demographics and mastectomy and flap characteristics were
 reviewed.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06415526
Non-Device Trial